News | November 10, 2023
Intermountain Health files complain against Dr. Reddy’s and others
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
Lokavant provides clinical trial intelligence
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
